- Disease: Acute SARS-CoV-2
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Retrospective, Single centre
- Objective: To evaluate the efficacy and safety of molnupiravir in treating COVID-19 in a real-life cohort
- Number of participants enrolled: 192
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults
- General population
- Elderly
- Hospital wide
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Molnupiravir
External Links
Other information
Funders/Sponsors:
- Università degli Studi di Sassari, Italy
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to